TY - JOUR AU - Chiorazzi, N. AU - Rai, K. R. AU - Ferrarini, M. PY - 2005 DA - 2005// TI - Chronic lymphocytic leukemia JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMra041720 DO - 10.1056/NEJMra041720 ID - Chiorazzi2005 ER - TY - JOUR AU - Zenz, T. AU - Mertens, D. AU - Küppers, R. AU - Döhner, H. AU - Stilgenbauer, S. PY - 2010 DA - 2010// TI - From pathogenesis to treatment of chronic lymphocytic leukaemia JO - Nat Rev Cancer VL - 10 ID - Zenz2010 ER - TY - JOUR AU - Grever, M. R. AU - Lucas, D. M. AU - Dewald, G. W. AU - Neuberg, D. S. AU - Reed, J. C. AU - Kitada, S. PY - 2007 DA - 2007// TI - Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997 JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.3089 DO - 10.1200/JCO.2006.08.3089 ID - Grever2007 ER - TY - JOUR AU - Hallek, M. PY - 2015 DA - 2015// TI - Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment JO - Am J Hematol VL - 90 UR - https://doi.org/10.1002/ajh.23979 DO - 10.1002/ajh.23979 ID - Hallek2015 ER - TY - JOUR AU - Binet, J. L. AU - Auquier, A. AU - Dighiero, G. AU - Chastang, C. AU - Piguet, H. AU - Goasguen, J. PY - 1981 DA - 1981// TI - A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis JO - Cancer VL - 48 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Binet1981 ER - TY - JOUR AU - Damle, R. N. AU - Wasil, T. AU - Fais, F. AU - Ghiotto, F. AU - Valetto, A. AU - Allen, S. L. PY - 1999 DA - 1999// TI - Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia JO - Blood VL - 94 ID - Damle1999 ER - TY - JOUR AU - Wiestner, A. AU - Rosenwald, A. AU - Barry, T. S. AU - Wright, G. AU - Davis, R. E. AU - Henrickson, S. E. PY - 2003 DA - 2003// TI - ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-10-3306 DO - 10.1182/blood-2002-10-3306 ID - Wiestner2003 ER - TY - JOUR AU - Bulian, P. AU - Shanafelt, T. D. AU - Fegan, C. AU - Zucchetto, A. AU - Cro, L. AU - Nückel, H. PY - 2014 DA - 2014// TI - CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.50.8515 DO - 10.1200/JCO.2013.50.8515 ID - Bulian2014 ER - TY - JOUR AU - Juliusson, G. AU - Oscier, D. G. AU - Fitchett, M. AU - Ross, F. M. AU - Stockdill, G. AU - Mackie, M. J. PY - 1990 DA - 1990// TI - Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities JO - N Engl J Med VL - 323 UR - https://doi.org/10.1056/NEJM199009133231105 DO - 10.1056/NEJM199009133231105 ID - Juliusson1990 ER - TY - JOUR AU - Döhner, H. AU - Stilgenbauer, S. AU - Benner, A. AU - Leupolt, E. AU - Kröber, A. AU - Bullinger, L. PY - 2000 DA - 2000// TI - Genomic aberrations and survival in chronic lymphocytic leukemia JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200012283432602 DO - 10.1056/NEJM200012283432602 ID - Döhner2000 ER - TY - JOUR AU - Cavazzini, F. AU - Hernandez, J. A. AU - Gozzetti, A. AU - Russo Rossi, A. AU - Angeli, C. AU - Tiseo, R. PY - 2008 DA - 2008// TI - Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis JO - Br J Haematol VL - 142 UR - https://doi.org/10.1111/j.1365-2141.2008.07227.x DO - 10.1111/j.1365-2141.2008.07227.x ID - Cavazzini2008 ER - TY - JOUR AU - Cuneo, A. AU - Rigolin, G. M. AU - Bigoni, R. AU - Angeli, C. AU - Veronese, A. AU - Cavazzini, F. PY - 2004 DA - 2004// TI - Chronic lymphocytic leukemia with 6q− shows distinct hematological features and intermediate prognosis JO - Leukemia VL - 18 UR - https://doi.org/10.1038/sj.leu.2403242 DO - 10.1038/sj.leu.2403242 ID - Cuneo2004 ER - TY - JOUR AU - Rigolin, G. M. AU - Giudice, I. AU - Formigaro, L. AU - Saccenti, E. AU - Martinelli, S. AU - Cavallari, M. PY - 2015 DA - 2015// TI - Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: clinical and biologic correlations JO - Genes Chromosomes Cancer VL - 54 UR - https://doi.org/10.1002/gcc.22293 DO - 10.1002/gcc.22293 ID - Rigolin2015 ER - TY - JOUR AU - Herling, C. D. AU - Klaumünzer, M. AU - Krings Rocha, C. AU - Altmüller, J. AU - Thiele, H. AU - Bahlo, J. PY - 2016 DA - 2016// TI - Complex karyotypes, KRAS and POT1 mutations impact outcome in CLL after chlorambucil based chemo- or chemoimmunotherapy JO - Blood VL - 128 UR - https://doi.org/10.1182/blood-2016-01-691550 DO - 10.1182/blood-2016-01-691550 ID - Herling2016 ER - TY - JOUR AU - Rossi, D. AU - Rasi, S. AU - Spina, V. AU - Bruscaggin, A. AU - Monti, S. AU - Ciardullo, C. PY - 2013 DA - 2013// TI - Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-09-458265 DO - 10.1182/blood-2012-09-458265 ID - Rossi2013 ER - TY - JOUR AU - Jeromin, S. AU - Weissmann, S. AU - Haferlach, C. AU - Dicker, F. AU - Bayer, K. AU - Grossmann, V. PY - 2014 DA - 2014// TI - SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2013.263 DO - 10.1038/leu.2013.263 ID - Jeromin2014 ER - TY - JOUR AU - Baliakas, P. AU - Hadzidimitriou, A. AU - Sutton, L. A. AU - Rossi, D. AU - Minga, E. AU - Villamor, N. PY - 2015 DA - 2015// TI - Recurrent mutations refine prognosis in chronic lymphocytic leukemia JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.196 DO - 10.1038/leu.2014.196 ID - Baliakas2015 ER - TY - JOUR AU - Oscier, D. G. AU - Rose-Zerilli, M. J. AU - Winkelmann, N. AU - Gonzalez de Castro, D. AU - Gomez, B. AU - Forster, J. PY - 2013 DA - 2013// TI - The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-05-429282 DO - 10.1182/blood-2012-05-429282 ID - Oscier2013 ER - TY - JOUR AU - Stilgenbauer, S. AU - Schnaiter, A. AU - Paschka, P. AU - Zenz, T. AU - Rossi, M. AU - Döhner, K. PY - 2014 DA - 2014// TI - Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2014-01-546150 DO - 10.1182/blood-2014-01-546150 ID - Stilgenbauer2014 ER - TY - JOUR AU - Pflug, N. AU - Bahlo, J. AU - Shanafelt, T. D. AU - Eichhorst, B. F. AU - Bergmann, M. A. AU - Elter, T. PY - 2014 DA - 2014// TI - Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-02-556399 DO - 10.1182/blood-2014-02-556399 ID - Pflug2014 ER - TY - JOUR PY - 2016 DA - 2016// TI - An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30029-8 DO - 10.1016/S1470-2045(16)30029-8 ID - ref21 ER - TY - JOUR AU - Parikh, S. A. AU - Strati, P. AU - Tsang, M. AU - West, C. P. AU - Shanafelt, T. D. PY - 2016 DA - 2016// TI - Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-10-620864 DO - 10.1182/blood-2015-10-620864 ID - Parikh2016 ER - TY - JOUR AU - Guièze, R. AU - Wu, C. J. PY - 2015 DA - 2015// TI - Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-02-585042 DO - 10.1182/blood-2015-02-585042 ID - Guièze2015 ER - TY - JOUR AU - Rossi, D. AU - Bruscaggin, A. AU - Spina, V. AU - Rasi, S. AU - Khiabanian, H. AU - Messina, M. PY - 2011 DA - 2011// TI - Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-08-373159 DO - 10.1182/blood-2011-08-373159 ID - Rossi2011 ER - TY - JOUR AU - Landau, D. A. AU - Tausch, E. AU - Taylor-Weiner, A. N. AU - Stewart, C. AU - Reiter, J. G. AU - Bahlo, J. PY - 2015 DA - 2015// TI - Mutations driving CLL and their evolution in progression and relapse JO - Nature VL - 526 UR - https://doi.org/10.1038/nature15395 DO - 10.1038/nature15395 ID - Landau2015 ER - TY - JOUR AU - Puente, X. S. AU - Pinyol, M. AU - Quesada, V. AU - Conde, L. AU - Ordóñez, G. R. AU - Villamor, N. PY - 2011 DA - 2011// TI - Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia JO - Nature VL - 475 UR - https://doi.org/10.1038/nature10113 DO - 10.1038/nature10113 ID - Puente2011 ER - TY - JOUR AU - Rossi, D. AU - Khiabanian, H. AU - Spina, V. AU - Ciardullo, C. AU - Bruscaggin, A. AU - Famà, R. PY - 2014 DA - 2014// TI - Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-11-539726 DO - 10.1182/blood-2013-11-539726 ID - Rossi2014 ER - TY - JOUR AU - Malcikova, J. AU - Stano-Kozubik, K. AU - Tichy, B. AU - Kantorova, B. AU - Pavlova, S. AU - Tom, N. PY - 2015 DA - 2015// TI - Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.297 DO - 10.1038/leu.2014.297 ID - Malcikova2015 ER - TY - JOUR AU - Rasi, S. AU - Khiabanian, H. AU - Ciardullo, C. AU - Terzi-di-Bergamo, L. AU - Monti, S. AU - Spina, V. PY - 2016 DA - 2016// TI - Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia JO - Haematologica VL - 101 UR - https://doi.org/10.3324/haematol.2015.136051 DO - 10.3324/haematol.2015.136051 ID - Rasi2016 ER - TY - JOUR AU - Sutton, L. A. AU - Ljungström, V. AU - Mansouri, L. AU - Young, E. AU - Cortese, D. AU - Navrkalova, V. PY - 2015 DA - 2015// TI - Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting JO - Haematologica VL - 100 UR - https://doi.org/10.3324/haematol.2014.109777 DO - 10.3324/haematol.2014.109777 ID - Sutton2015 ER - TY - JOUR AU - Vollbrecht, C. AU - Mairinger, F. D. AU - Koitzsch, U. AU - Peifer, M. AU - Koenig, K. AU - Heukamp, L. C. PY - 2015 DA - 2015// TI - Comprehensive analysis of disease-related genes in chronic lymphocytic leukemia by multiplex PCR-based next generation sequencing JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0129544 DO - 10.1371/journal.pone.0129544 ID - Vollbrecht2015 ER - TY - JOUR AU - Hallek, M. AU - Cheson, B. D. AU - Catovsky, D. AU - Caligaris-Cappio, F. AU - Dighiero, G. AU - Döhner, H. PY - 2008 DA - 2008// TI - Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-06-093906 DO - 10.1182/blood-2007-06-093906 ID - Hallek2008 ER - TY - JOUR AU - Matutes, E. AU - Owusu-Ankomah, K. AU - Morilla, R. AU - Garcia Marco, J. AU - Houlihan, A. AU - Que, T. H. PY - 1994 DA - 1994// TI - The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL JO - Leukemia VL - 8 ID - Matutes1994 ER - TY - JOUR AU - Rigolin, G. M. AU - Cibien, F. AU - Martinelli, S. AU - Formigaro, L. AU - Rizzotto, L. AU - Tammiso, E. PY - 2012 DA - 2012// TI - Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with “normal” FISH: correlations with clinicobiologic parameters JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-11-395269 DO - 10.1182/blood-2011-11-395269 ID - Rigolin2012 ER - TY - JOUR AU - Rigolin, G. M. AU - Maffei, R. AU - Rizzotto, L. AU - Ciccone, M. AU - Sofritti, O. AU - Daghia, G. PY - 2010 DA - 2010// TI - Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24961 DO - 10.1002/cncr.24961 ID - Rigolin2010 ER - TY - JOUR AU - Bardi, A. AU - Cavazzini, F. AU - Rigolin, G. M. AU - Tammiso, E. AU - Volta, E. AU - Pezzolo, E. PY - 2011 DA - 2011// TI - Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma JO - J Biomed Biotechnol VL - 2011 UR - https://doi.org/10.1155/2011/691493 DO - 10.1155/2011/691493 ID - Bardi2011 ER - TY - JOUR AU - Rigolin, G. M. AU - Saccenti, E. AU - Rizzotto, L. AU - Ferracin, M. AU - Martinelli, S. AU - Formigaro, L. PY - 2014 DA - 2014// TI - Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients JO - Oncotarget VL - 5 ID - Rigolin2014 ER - TY - JOUR AU - Chang, F. AU - Li, M. M. PY - 2013 DA - 2013// TI - Clinical application of amplicon-based next-generation sequencing in cancer JO - Cancer Genet VL - 206 UR - https://doi.org/10.1016/j.cancergen.2013.10.003 DO - 10.1016/j.cancergen.2013.10.003 ID - Chang2013 ER - TY - JOUR AU - Schnaiter, A. AU - Paschka, P. AU - Rossi, M. AU - Zenz, T. AU - Bühler, A. AU - Winkler, D. PY - 2013 DA - 2013// TI - NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-03-488197 DO - 10.1182/blood-2013-03-488197 ID - Schnaiter2013 ER - TY - JOUR AU - Rossi, D. AU - Fangazio, M. AU - Rasi, S. AU - Vaisitti, T. AU - Monti, S. AU - Cresta, S. PY - 2012 DA - 2012// TI - Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-12-395673 DO - 10.1182/blood-2011-12-395673 ID - Rossi2012 ER - TY - JOUR AU - Wang, L. AU - Lawrence, M. S. AU - Wan, Y. AU - Stojanov, P. AU - Sougnez, C. AU - Stevenson, K. PY - 2011 DA - 2011// TI - SF3B1 and other novel cancer genes in chronic lymphocytic leukemia JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1109016 DO - 10.1056/NEJMoa1109016 ID - Wang2011 ER - TY - JOUR AU - Fabbri, G. AU - Rasi, S. AU - Rossi, D. AU - Trifonov, V. AU - Khiabanian, H. AU - Ma, J. PY - 2011 DA - 2011// TI - Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation JO - J Exp Med VL - 208 UR - https://doi.org/10.1084/jem.20110921 DO - 10.1084/jem.20110921 ID - Fabbri2011 ER - TY - JOUR AU - Quesada, V. AU - Conde, L. AU - Villamor, N. AU - Ordóñez, G. R. AU - Jares, P. AU - Bassaganyas, L. PY - 2011 DA - 2011// TI - Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia JO - Nat Genet VL - 44 UR - https://doi.org/10.1038/ng.1032 DO - 10.1038/ng.1032 ID - Quesada2011 ER - TY - JOUR AU - Landau, D. A. AU - Carter, S. L. AU - Stojanov, P. AU - McKenna, A. AU - Stevenson, K. AU - Lawrence, M. S. PY - 2013 DA - 2013// TI - Evolution and impact of subclonal mutations in chronic lymphocytic leukemia JO - Cell VL - 152 UR - https://doi.org/10.1016/j.cell.2013.01.019 DO - 10.1016/j.cell.2013.01.019 ID - Landau2013 ER - TY - JOUR AU - Dicker, F. AU - Herholz, H. AU - Schnittger, S. AU - Nakao, A. AU - Patten, N. AU - Wu, L. PY - 2009 DA - 2009// TI - The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype JO - Leukemia VL - 23 UR - https://doi.org/10.1038/leu.2008.274 DO - 10.1038/leu.2008.274 ID - Dicker2009 ER - TY - JOUR AU - Nadeu, F. AU - Delgado, J. AU - Royo, C. AU - Baumann, T. AU - Stankovic, T. AU - Pinyol, M. PY - 2016 DA - 2016// TI - Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-07-659144 DO - 10.1182/blood-2015-07-659144 ID - Nadeu2016 ER - TY - JOUR AU - Guièze, R. AU - Robbe, P. AU - Clifford, R. AU - Guibert, S. AU - Pereira, B. AU - Timbs, A. PY - 2015 DA - 2015// TI - Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-05-647578 DO - 10.1182/blood-2015-05-647578 ID - Guièze2015 ER - TY - JOUR AU - Thompson, P. A. AU - O’Brien, S. M. AU - Wierda, W. G. AU - Ferrajoli, A. AU - Stingo, F. AU - Smith, S. C. PY - 2015 DA - 2015// TI - Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens JO - Cancer VL - 121 UR - https://doi.org/10.1002/cncr.29566 DO - 10.1002/cncr.29566 ID - Thompson2015 ER - TY - JOUR AU - Rossi, D. AU - Terzi-di-Bergamo, L. AU - Paoli, L. AU - Cerri, M. AU - Ghilardi, G. AU - Chiarenza, A. PY - 2015 DA - 2015// TI - Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-05-647925 DO - 10.1182/blood-2015-05-647925 ID - Rossi2015 ER - TY - JOUR AU - Cuneo, A. AU - Cavazzini, F. AU - Ciccone, M. AU - Daghia, G. AU - Sofritti, O. AU - Saccenti, E. PY - 2014 DA - 2014// TI - Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups JO - Cancer Med VL - 3 UR - https://doi.org/10.1002/cam4.226 DO - 10.1002/cam4.226 ID - Cuneo2014 ER - TY - JOUR AU - Pospisilova, S. AU - Gonzalez, D. AU - Malcikova, J. AU - Trbusek, M. AU - Rossi, D. AU - Kater, A. P. PY - 2012 DA - 2012// TI - ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2012.25 DO - 10.1038/leu.2012.25 ID - Pospisilova2012 ER -